Navigation Links
year in Biological Technology
Repligen Reports First Quarter Fiscal Year 2010 Financial Results
WALTHAM, Mass., Aug. 6 /PRNewswire-FirstCall/ -- Repligen Corporation (Nasdaq: RGEN ) today reported results for the first quarter fiscal year 2010, ended June 30, 2009. Total revenue for the quarter was $5,061,000 compared to total revenue of $13,660,000 for the first quarter of fiscal ye...Techne Corporation Releases Unaudited Fourth Quarter Results for Fiscal Year 2009
MINNEAPOLIS, Aug. 4 /PRNewswire-FirstCall/ -- Techne Corporation's (Nasdaq: TECH ) consolidated net earnings for the quarter ended June 30, 2009 decreased 6.9% to $25.4 million or $.68 per diluted share compared with $27.3 million or $.70 per diluted share for the quarter ended June 30...EMERYVILLE, Calif., Aug. 3 /PRNewswire-FirstCall/ -- Bionovo, Inc. (Nasdaq: BNVI ) announced today that it will release financial results for the second quarter of fiscal year 2009 ended June 30, 2009 on Monday, August 10, 2009. The Company will conduct a conference call and web cast t...
Repligen Announces Conference Call of First Quarter Fiscal Year 2010 Results
WALTHAM, Mass., July 30 /PRNewswire-FirstCall/ -- Repligen Corporation (Nasdaq: RGEN ) announced today that the Company President and Chief Executive Officer, Walter C. Herlihy, Ph.D., will host a conference call and webcast on Thursday, August 6th, 2009 at 10:00 a.m. EDT, to report fi...ST. LOUIS, July 23 /PRNewswire-FirstCall/ --Sigma-Aldrich Corporation (Nasdaq: SIAL ), a leading Life Science and High Technology company, reported second quarter 2009 diluted EPS of $0.68 compared to $0.70 in the second quarter of 2008. For the six months ended June 30, 2009, reporte...
Varian, Inc. to Webcast Conference Call on Third Quarter Fiscal Year 2009 Financial Results
PALO ALTO, Calif., July 21,/PRNewswire-FirstCall/ -- Varian, Inc. (NasdaqGS: VARI) plans to release its financial results for the third quarter of its fiscal year 2009 after 1:00 p.m. Pacific Time (PT) on Wednesday, July 29, 2009. A live webcast (in listen-only mode) of its investor conf...China-Biotics, Inc. Reports Fourth Quarter and Full Year Fiscal 2009 Financial Results
SHANGHAI, July 15 /PRNewswire-Asia-FirstCall/ -- China-Biotics, Inc. (Nasdaq: CHBT ) ("China-Biotics", "the Company"), a leading Chinese firm specializing in the manufacture, research, development, marketing and distribution of probiotics products, today announced its financial results for t...PAREXEL Announces Date of Fourth Quarter and Fiscal Year 2009 Earnings Release and Conference Call
BOSTON, July 13 /PRNewswire-FirstCall/ -- PAREXEL International Corporation (Nasdaq: PRXL ) will release Fourth Quarter and Fiscal Year 2009 financial results on Monday, August 10, 2009 after the close of the stock market. The announcement will be available on PAREXEL's website at www...SHANGHAI, July 10 /PRNewswire-Asia-FirstCall/ -- China-Biotics, Inc. (Nasdaq: CHBT ) ("China-Biotics," "the Company"), a leading Chinese firm specializing in the research, development, manufacture, marketing and distribution of probiotics dietary supplements, today announced it will host a c...
Kewaunee Scientific Reports Record Results Net Earnings for Year Increase 36%, Sales Increase 16%
STATESVILLE, N.C., June 24 /PRNewswire-FirstCall/ -- Kewaunee Scientific Corporation (Nasdaq: KEQU ) today reported record sales, earnings, and order backlog for its fiscal year ended April 30, 2009. Net earnings for the year increased 36% to $4,247,000, or $1.66 per diluted share, up from...Repligen Reports Fourth Quarter and Fiscal Year 2009 Financial Results
WALTHAM, Mass., June 11 /PRNewswire-FirstCall/ -- Repligen Corporation (Nasdaq: RGEN ) today reported results for the fourth quarter and fiscal year 2009, ended March 31, 2009. Total revenue for fiscal year 2009 was $29,362,000 compared to total revenue of $19,296,000 for fiscal year 2008 ended...Repligen Announces Conference Call of Fourth Quarter and Fiscal Year 2009 Results
Thursday, June 11th, 10:00 a.m. EDT WALTHAM, Mass., June 4 /PRNewswire-FirstCall/ -- Repligen Corporation (Nasdaq: RGEN ) announced today that the Company President and Chief Executive Officer, Walter C. Herlihy, Ph.D., will host a conference call and webcast on Thursday, June 11th, 2009 a...Shire begins the year with a strong performance
PHILADELPHIA and DUBLIN, April 30 /PRNewswire-FirstCall/ -- Shire plc (LSE: SHP, NASDAQ: SHPGY ) the global specialty biopharmaceutical company, announces results for the three months to March 31, 2009. Financial Highlights ...Covance Reports First Quarter Revenue of $441M and EPS of $0.63; Updates Full Year Financial Targets
PRINCETON, N.J., April 29 /PRNewswire-FirstCall/ -- Covance Inc. (NYSE: CVD ) today reported earnings for its first quarter ended March 31, 2009 of $0.63 per diluted share versus $0.76 per diluted share in the first quarter of 2008 (or $0.73 per diluted share after excluding the centralized ECG ...2008 a Record Year for Gerresheimer
DUSSELDORF, Germany, April 29 /PRNewswire-FirstCall/ -- - Strong Focus on the Markets of Pharma & Life Science - Annual General Meeting Passes Dividend of EUR0.40 per Share The Annual General Meeting of Gerresheimer AG today passed an unchanged dividend of EUR0.40 per ...Techne Corporation Releases Unaudited Third Quarter Results for Fiscal Year 2009
MINNEAPOLIS, April 28 /PRNewswire-FirstCall/ -- Techne Corporation's (Nasdaq: TECH ) consolidated net earnings for the quarter ended March 31, 2009 decreased 6.6% to $27.6 million or $.74 per diluted share compared with $29.6 million or $.76 per diluted share for the quarter ended March 31, 2008...PAREXEL Reports Third Quarter Fiscal Year 2009 Financial Results
- Consolidated service revenue of $264.5 million grows 7.8% year-over-year - Operating margin of 10.0% - Diluted earnings per share of $0.25 - Net quarterly book-to-bill ratio equates to 1.25 BOSTON, April 27 /PRNewswire-FirstCall/ -- PAREXEL International Corporation (Nasdaq: ...China Yongxin Pharmaceuticals, Inc. Announces 2008 Fourth Quarter and Full Year Financial Results
CHANGCHUN, China and LOS ANGELES, April 23 /PRNewswire-Asia-FirstCall/ -- - Fourth Quarter 2008 Revenue Increased 28.6% to $14.1 Million, with Net Income was $0.9 Million and Diluted EPS of $.03 - 2008 Revenues Increased 23.5% to $59.1 Million vs. 2007 - 2008 Gross Profit ...SINGAPORE, April 21 /PRNewswire-Asia/ -- Moleac has been named the Singapore Entrepreneurial Company of the Year, by Frost & Sullivan. This award recognizes companies that have pushed the boundaries of excellence in the healthcare industry and acknowledges Moleac's outstanding performance ...
China Sky One Medical, Inc. Announces Record Fourth Quarter and Fiscal Year 2008 Results
HARBIN, China, April 15 /PRNewswire-Asia-FirstCall/ -- China Sky One Medical, Inc. ("China Sky One Medical" or "the Company") (Nasdaq: CSKI ), a leading fully integrated pharmaceutical company producing over-the-counter drugs in the People's Republic of China ("PRC"), today announced record ...HARBIN, China, April 15 /PRNewswire-Asia-FirstCall/ -- China Sky One Medical, Inc. ("China Sky One Medical" or "the Company") (Nasdaq: CSKI ), a leading fully integrated pharmaceutical company producing over-the-counter drugs in the People's Republic of China ("PRC"), today announced that it...
Varian, Inc. to Webcast Conference Call on Second Quarter Fiscal Year 2009 Financial Results
PALO ALTO, Calif., April 15 /PRNewswire-FirstCall/ -- Varian, Inc. (NasdaqGS: VARI) plans to release its financial results for the second quarter of its fiscal year 2009 after 1:00 p.m. Pacific Time (PT) on Wednesday, April 29, 2009. A live webcast (in listen-only mode) of its investor conference ...Health Robotics Reports Triple-Digit-Growth Across All Financial Metrics in Fiscal Year 2008
BOLZANO, Italy, April 14 /PRNewswire/ -- Health Robotics today announced audited results for FY2008 ending December 31, 2008, delivering record levels of firm purchase orders, revenue, earnings and cash flow. Revenues in FY2008 were EUR8.2 million, a 161% increase year-over-year as the ...OncoGenex Pharmaceuticals Named Life Sciences Company of the Year by LifeSciences British Columbia
BOTHELL, WA, and VANCOUVER, April 9 /PRNewswire-FirstCall/ - OncoGenex Pharmaceuticals, Inc. ("OncoGenex" or the "Company") (NASDAQ: OGXI ), announced today that it has been named the 2009 Life Sciences Company of the Year by LifeSciences British Columbia. This annual award is presented by LifeS...Sinovac Reports Unaudited Full Year 2008 and Fourth Quarter Financial Results with Financial Tables
BEIJING, April 9 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (NYSE Amex: SVA ), a leading developer and provider of vaccines in China, today announced the Company's unaudited financial results for the three and twelve month periods ended December 31, 2008. Full Year 2008 Financial High...Sinovac Reports Unaudited Full Year 2008 and Fourth Quarter Financial Results
BEIJING, April 9 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (NYSE Amex: SVA ), a leading developer and provider of vaccines in China, today announced the Company's unaudited financial results for the three and twelve month periods ended December 31, 2008. Full Year 2008 Financial High...ChromaDex Announces 2008 Year End Financial Results
IRVINE, Calif., April 3 /PRNewswire-FirstCall/ -- ChromaDex Corporation, (OTC Bulletin Board: CDXC) a leader in phytochemical reference standards and contract research, today announced financial results for the 2008 Fiscal Year. On a reported basis calculated in accordance with U.S. Generally Acce...NovaBay Pharmaceuticals, Inc. Announces Fourth Quarter and Full Year 2008 Financial Results
2008 and Recent Events Highlighted EMERYVILLE, Calif., April 1, /PRNewswire-FirstCall/ -- NovaBay Pharmaceuticals, Inc. (NYSE Amex: NBY ), a mid-stage biopharmaceutical company developing first-in-class anti-infective products for the treatment and prevention of a wide range of infections w...Sinovac to Host Conference Call to Report Fourth Quarter and Full Year 2008 Financial Results
BEIJING, April 1 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (Amex: SVA ), a leading provider of vaccines in China, today announced that it will host a conference call on Thursday, April 9, 2009 at 9:00 a.m. ET (9 p.m. China Standard Time) to review the Company's financial results for the four...BioSpecifics Technologies Corp. Reports Fourth Quarter and Full Year 2008 Financial Results
LYNBROOK, N.Y., March 30 /PRNewswire-FirstCall/ -- BioSpecifics Technologies Corp. (Nasdaq: BSTC ), a biopharmaceutical company developing first in class collagenase-based products, today announced its financial results for the fourth quarter and full year ended December 31, 2008. "We are ...TorreyPines Therapeutics Reports Fourth Quarter and Full Year 2008 Results
LA JOLLA, Calif., March 27 /PRNewswire/ -- TorreyPines Therapeutics, Inc. (Nasdaq: TPTX ) today announced financial results for the fourth quarter and year ended December 31, 2008. For the full year 2008, the Company posted revenue of $6.1 million and a net loss of $22.8 million. Cash and ca...International Isotopes Inc. Announces Year End Financial Results
Company Shows a 19% Increase In Total Revenue To $5.6 Million; 34% Increase in Gross Profit IDAHO FALLS, Idaho, March 27 /PRNewswire-FirstCall/ -- International Isotopes Inc. (OTC Bulletin Board: INIS) announces the financial results for fiscal year ended December 31, 2008. Total Re...Cornerstone Therapeutics Reports Year Ended December 31, 2008 Financial Results
CARY, N.C., March 26 /PRNewswire-FirstCall/ -- Cornerstone Therapeutics Inc. (Nasdaq: CRTX ), a specialty pharmaceutical company focused on acquiring, developing and commercializing significant products primarily for the respiratory market, today reported financial results for the year ended Dec...ADVENTRX Pharmaceuticals, Inc. Reports Fourth Quarter and Full Year 2008 Financial Results
SAN DIEGO, March 25 /PRNewswire-FirstCall/ -- ADVENTRX Pharmaceuticals, Inc. (NYSE Amex: ANX ) today reported financial results for the fourth quarter and year ended December 31, 2008. "2008 was a transition year for ADVENTRX in which we advanced a new business model focused on lower-risk r...Transgenomic, Inc. Reports Fourth Quarter and Fiscal Year 2008 Results
OMAHA, Neb., March 18 /PRNewswire-FirstCall/ -- Transgenomic, Inc. (OTC Bulletin Board: TBIO) today announced financial results for the fourth quarter and year ended December 31, 2008. The Company's financial results are presented in the tables that follow. Fourth Quarter 2008 The Company...BMP Sunstone Reports Fourth Quarter and Full Year 2008 Financial Results
PLYMOUTH MEETING, Pa., March 17 /PRNewswire-Asia-FirstCall/ -- BMP Sunstone Corporation (Nasdaq: BJGP ) ("BMP Sunstone" or the "Company"), today announced financial results for the fourth quarter and fiscal year ended December 31, 2008. Financial Highlights as of December 31, 2008: ...BioMS Medical Announces 2008 Year End Results
Toronto Stock Exchange Symbol: MS EDMONTON, March 17 /PRNewswire-FirstCall/ - BioMS Medical Corp. (TSX: MS), a leading developer in the treatment of multiple sclerosis (MS), today announced financial and operational results for the year ended December 31, 2008. "Dirucotide has demonstrated ...AutoImmune Inc. Reports 2008 Fourth Quarter and Year End Financial Results
PASADENA, Calif., March 16 /PRNewswire-FirstCall/ -- AutoImmune Inc. (OTC Bulletin Board: AIMM) today reported a net loss of $129,000, or $0.01 per share basic and diluted, for the three months ended December 31, 2008, compared with a net loss of $56,000, or break even per share basic and diluted,...Cell Therapeutics, Inc. (CTI) Reports 2008 Fourth Quarter and Year End Financial Results
Net operating expenses decreased by 33% in 2008; Forecast cutting net operating expenses by approximately 50% in 2009 CTI expects to complete pixantrone NDA submission in Q2 2009 SEATTLE, March 16 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc. (CTI) (Nasdaq and MTA: CTIC) today repo...Dendreon Reports Fourth Quarter and 2008 Year End Financial Results
SEATTLE, March 12 /PRNewswire-FirstCall/ -- Dendreon Corporation (Nasdaq: DNDN ) today reported results for the year and quarter ended December 31, 2008. Revenues for the year ended December 31, 2008 were $111,000 compared to $743,000 for the year ended December 31, 2007. Revenues for the fourth...Other TagsOther Contents
GeneralEquineUbiquitinCardiovascularRapidVUETotalGastrointestinalNeurologicalExtractiOsteoclastsPPARGammaDenhardtImageXpressVibratome
(Date:5/21/2013)... Researchers at USC have found that a class of ... mice. , The drugs, known as "TSPO ligands," ... "We looked at the effects of TSPO ligand in ... stage, and in aged mice when pathology was quite ... Davis School of Gerontology. "TSPO ligand reduced measures of ...
(Date:5/21/2013)... Researchers at the University of Illinois at Chicago College of ... and stores fat -- its main energy source -- and ... disease, under a new $2 million, 4-year grant from the ... heart changes how it uses fuel for energy. These changes ... disease and are different in men and women, says E. ...
(Date:5/21/2013)... charted the path of insulin action in cells in ... blueprint for understanding what goes wrong in diabetes. ... Professor David James from Sydney,s Garvan Institute of Medical ... of the prestigious journal Cell Metabolism . , ... very important role in the body because it helps ...
Breaking Biology News(10 mins):Drugs found to both prevent and treat Alzheimer's disease in mice 2Do men's and women's hearts burn fuel differently? 2Insight into the dazzling impact of insulin in cells 2Insight into the dazzling impact of insulin in cells 3(Date:5/21/2013)... May 21, 2013 Daily Gossip Magazine published ... their readers and keep people informed on the latest weight ... reporters have prepared an in-depth review of Kyle ... useful for readers who want to lose weight or stay ... Daily Gossip the program was created by a popular fitness ...
(Date:5/21/2013)... 2013 Parker Waichman LLP, a national law ... defective medical devices, is offering remarks on the closing argument ... of Fred E. Taylor v. Intuitive Surgical, 09-2-03136-5, Superior Court, ... 2013, Bloomberg report noted that the plaintiff’s attorney, ... dealership” in how it deployed its strategy to train doctors ...
(Date:5/21/2013)... York (PRWEB) May 21, 2013 Parker ... the rights of victims injured by defective medical devices, ... Bone & Joint Surgery on May 15, 2013. The ... used to identify complications that occur in patients with ... of failure. ( http://www.jbjs.org/article.aspx?articleid=1684770 ) , ...
(Date:5/21/2013)... results from SOURCE XT one of the largest, ... reported today at EuroPCR 2013 show good clinical outcomes ... success for all access approaches, valve sizes and delivery ... 2688 consecutively enrolled patients (mean age 81.5 years) undergoing ... centres in 17 countries between July 2010 and October ...
(Date:5/21/2013)... The federal judge overseeing the litigation ... lawsuits in U.S. District Court, Northern District of Georgia, ... from Plaintiffs’ Counsel to conduct Ex Parte interviews with ... Order grants that request, and sets forth procedures under ... Medical Technology, Inc., Conserve Hip Implant Products Liability Litigation, ...
Breaking Medicine News(10 mins):Health News:Customized Fat Loss Plan Review and Diet Secrets Revealed By Daily Gossip Magazine 2Health News:Da Vinci Robotic Surgery Lawsuit: Parker Waichman LLP Reacts to Plaintiff’s Attorney’s Closing Argument in Which He Describes Intuitive Surgical as a Car Dealership 2Health News:Da Vinci Robotic Surgery Lawsuit: Parker Waichman LLP Reacts to Plaintiff’s Attorney’s Closing Argument in Which He Describes Intuitive Surgical as a Car Dealership 3Health News:Parker Waichman LLP Comments on New Study Showing that MRI is Useful for Predicting Failure of Metal-on-Metal Hip Implants 2Health News:Parker Waichman LLP Comments on New Study Showing that MRI is Useful for Predicting Failure of Metal-on-Metal Hip Implants 3Health News:Wright Hip Lawsuit News: Bernstein Liebhard LLP Notes Issuance of New Order in Federal Wright Conserve Hip Replacement Litigation 2Health News:Wright Hip Lawsuit News: Bernstein Liebhard LLP Notes Issuance of New Order in Federal Wright Conserve Hip Replacement Litigation 3[0] Customized Fat Loss Plan Review and Diet Secrets Revealed By Daily Gossip Magazine[0] Da Vinci Robotic Surgery Lawsuit: Parker Waichman LLP Reacts to Plaintiff’s Attorney’s Closing Argument in Which He Describes Intuitive Surgical as a Car Dealership[0] Parker Waichman LLP Comments on New Study Showing that MRI is Useful for Predicting Failure of Metal-on-Metal Hip Implants[0] Post-approval TAVI registry shows high rates of device success at 1 year[0] Wright Hip Lawsuit News: Bernstein Liebhard LLP Notes Issuance of New Order in Federal Wright Conserve Hip Replacement Litigation
| Copyright © 2003-2012 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |